Wellmatix

Wellmatix is an AI-powered Therapeutics discovery company developing next-generation Antibody-Drug Conjugate (ADC) platforms. Its proprietary algorithms accelerate early-stage discovery, reduce costs, and improve success rates in oncology and immunotherapy development.

  • Category: Medtech
  • Customer segment: B2B, B2G
  • Development stage: On market
  • Funding stage: Seed
  • Founding year: 2021
  • Team members: 12